Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children

Archives of Disease in Childhood

Volumn 95, Issue 6, 2010, Pages 478-481

  Rudin, Christoph ^a   Wolbers, Marcel ^b   Nadal, David ^c   Rickenbach, Martin ^a,d   Bucher, Heiner C ^b   Aebi, C ^f   Bar W ^f   Berger, Ch ^f   Besson, F ^f   Buhlmann U ^f   Cheseaux, J J ^e   Desgrandchamps, D ^f   Diana, A ^f   Duppenthaler, A ^f   Gervaix, A ^f   Gnehm, H P ^f   Heininger, U ^f   Hunziker, U A ^f   Kind, C ^f   Kuchler, H ^f   Loher, A ^f   Masserey Spicher, V ^f   Myers, C ^f   Posfay Barbe, C ^f   Schaad, U B ^f   Siegrist, C A ^f   Stahelin J ^f   Vaudaux, B ^f   Wyler Lazarevic, C A ^f   Zingg, W ^f   Battegay, M ^e   Bernasconi, E ^e   Boni J ^e   Brazzola, P ^e   Burgisser Ph ^e   Calmy, A ^e   Cattacin, S ^e   Cavassini, M ^e   Drack, G ^e   Dubs, R ^e   Egger, M ^e   Elzi, L ^e   Fischer, M ^e   Flepp, M ^e   Fontana, A ^e   Francioli, P ^e   Furrer, H J ^a   Fux, C ^a   Gayet Ageron, A ^a   Gerber, S ^a   Gorgievski, M ^a   Gunthard H ^a   Gyr, Th ^a   Hirsch, H ^a   Hirschel, B ^a   Hosli I ^a   Husler M ^a   Kaiser, L ^a   Kahlert, Ch ^a   Karrer, U ^a   Klimkait, Th ^a   Ledergerber, B ^a   Martinetti, G ^a   Martinez, B ^a   Muller N ^a   Paccaud, F ^a   Pantaleo, G ^a   Raio, L ^a   Rauch, A ^a   Regenass, S ^a   Schmid, P ^f   Schultze, D ^f   Schupbach J ^f   Speck, R ^f   Taffe P ^f   Telenti, A ^f   Trkola, A ^f   Vernazza, P ^f   Weber, R ^f   Wyler, C A ^f   Yerly, S ^f   more..

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d Swiss HIV Cohort Study   (Switzerland)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f Basel UKBB ^*

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; RITONAVIR; ZIDOVUDINE;

ABNORMAL LABORATORY RESULT; ARTICLE; BLOOD CELL COUNT; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILD CARE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOLOGY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE; VIRUS LOAD;

ADOLESCENT; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; PROSPECTIVE STUDIES; PYRIMIDINONES; RITONAVIR; TREATMENT OUTCOME; VIRAL LOAD;

EID: 77953696040     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.169375     Document Type: Article

References (5)

1. Rudin C, Burri M, Shen Y, et al. Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children. Pediatr Infect Dis J 2008;27:431-7.
2. Swiss HIV Cohort Study. http://www.shcs.ch.
3. Division of Microbiology and Infectious Diseases (DMID). Pediatric Toxicity Tables, November 2007. http://www3.niaid.nih.gov/NR/rdonlyres/B7B341E5- 2F99-4449-AABA-384B2BAD0E19/0/ dmidpedtox.doc.
4. Murphy RL, Brun S, Hicks C, et al. ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results. AIDS 2001;15:F1-9. (Pubitemid 32055772)
5. Kline MW, Rugina S, Ilie M, et al. Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir- containing highly active antiretroviral therapy. Pediatrics 2007;119:e1116-20. (Pubitemid 46715649)